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Abstract
The term corneal dystrophy embraces a heterogenous group of bilateral genetically determined
non-inflammatory corneal diseases that are restricted to the cornea. The designation is imprecise
but remains in vogue because of its clinical value. Clinically, the corneal dystrophies can be divided
into three groups based on the sole or predominant anatomical location of the abnormalities. Some
affect primarily the corneal epithelium and its basement membrane or Bowman layer and the
superficial corneal stroma (anterior corneal dystrophies), the corneal stroma (stromal corneal
dystrophies), or Descemet membrane and the corneal endothelium (posterior corneal
dystrophies). Most corneal dystrophies have no systemic manifestations and present with variable
shaped corneal opacities in a clear or cloudy cornea and they affect visual acuity to different
degrees. Corneal dystrophies may have a simple autosomal dominant, autosomal recessive or X-
linked recessive Mendelian mode of inheritance. Different corneal dystrophies are caused by
mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.
Knowledge about the responsible genetic mutations responsible for these disorders has led to a
better understanding of their basic defect and to molecular tests for their precise diagnosis. Genes
for other corneal dystrophies have been mapped to specific chromosomal loci, but have not yet
been identified. As clinical manifestations widely vary with the different entities, corneal dystrophies
should be suspected when corneal transparency is lost or corneal opacities occur spontaneously,
particularly in both corneas, and especially in the presence of a positive family history or in the
offspring of consanguineous parents. Main differential diagnoses include various causes of
monoclonal gammopathy, lecithin-cholesterol-acyltransferase deficiency, Fabry disease, cystinosis,
tyrosine transaminase deficiency, systemic lysosomal storage diseases (mucopolysaccharidoses,
lipidoses, mucolipidoses), and several skin diseases (X-linked ichthyosis, keratosis follicularis
spinolosa decalvans). The management of the corneal dystrophies varies with the specific disease.
Some are treated medically or with methods that excise or ablate the abnormal corneal tissue, such
as deep lamellar endothelial keratoplasty (DLEK) and phototherapeutic keratectomy (PTK). Other
less debilitating or asymptomatic dystrophies do not warrant treatment. The prognosis varies from
minimal effect on the vision to corneal blindness, with marked phenotypic variability.
Background: disease name, synonyms and 
included diseases
Traditionally, corneal dystrophy is defined as a heteroge-
nous group of bilateral genetically determined non-
inflammatory diseases that are restricted to the cornea and
not associated with inflammation or non-corneal mani-
festations. However, these generalities are not features of
all corneal dystrophies. Some of these disorders, such as
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macular corneal dystrophy and Schnyder corneal dystro-
phy have systemic manifestations. Familial amyloid
polyneuropathy type IV (Finnish or Meretoja type, Mere-
toja syndrome, *MIM #105120), can be confused clini-
cally and histopathologically with lattice corneal
dystrophy type I and is commonly classified as a corneal
dystrophy type II. Historically, an accumulation of small
gray variable shaped punctate opacities of variable shape
in the central deep corneal stroma immediately anterior
to Descemet membrane were designated deep filiform
dystrophy and cornea farinata because of their resem-
blance to commas, circles, lines, threads (filiform), flour
(farina) or dots. These abnormalities are now known to
accompany X-linked ichthyosis (steroid sulfatase defi-
ciency, MIM #308100) caused by STS (steroid sulfatase)
gene mutations and are currently usually not included
under the rubric of the corneal dystrophies. In the past,
the designation vortex corneal dystrophy (corneal verticil-
lata) was applied to a corneal disorder characterized by
the presence of innumerable tiny brown spots arranged in
curved whirlpool-like lines in the superficial cornea. An
autosomal dominant mode of transmission was initially
suspected, but later it was realized that these individuals
were affected hemizygous males and asymptomatic
female carriers of an X-linked systemic metabolic disease
caused by a deficiency of α-galactosidase (Fabry disease,
MIM #301500). While an entity designated epithelial
basement membrane dystrophy (map-dot-fingerprint or
Cogan microcystic dystrophy) is widely regarded as a "cor-
neal dystrophy" by many ophthalmologists, this condi-
tion is not a distinct inherited disorder, but rather a non-
specific reaction to a variety of corneal insults. Extensive
reviews of the corneal dystrophies and other genetic disor-
ders of the cornea have been published [1-4] and the
reader should refer to them for a comprehensive bibliog-
raphy.
Definition
The term corneal dystrophy refers to a heterogenous
group of genetically determined corneal diseases that are
restricted to the cornea (Table 1). The designation corneal
dystrophy is imprecise but remains in vogue because of its
clinical value. Typically, the conditions included under
the umbrella of corneal dystrophy are bilateral spontane-
ous corneal disorders that vary in clinical severity and in
their signs and symptoms. Most corneal dystrophies have
no systemic manifestations and present with variable
shaped corneal opacities in a clear or cloudy cornea and
they affect visual acuity to different degrees. Diagnoses
can be established on clinical grounds and this may be
enhanced with studies on surgically excised corneal tissue
and in some cases with molecular genetic analyses. The
management options and outcomes following therapy
vary with the condition under consideration. Clinically,
the corneal dystrophies are classified with respect to the
layer of cornea involved and can be divided into three
groups based on the sole or predominant anatomical
location of the abnormalities. Some affect primarily the
corneal epithelium and its basement membrane or Bow-
man layer and the superficial corneal stroma (anterior or
superficial corneal dystrophies), the corneal stroma (stro-
mal corneal dystrophies), or Descemet membrane and the
corneal endothelium (posterior corneal dystrophies).
Most of the corneal dystrophies are of Mendelian inherit-
ance (autosomal dominant, autosomal recessive or X-
linked recessive) with some phenotype diversity and a var-
iable degree of penetrance. The age of onset of the differ-
ent types of corneal dystrophies is variable and reflects
different underlying pathogenic defects (Table 2). A few
corneal dystrophies are congenital and represent develop-
mental anomalies.
A. Superficial corneal dystrophies
This group of corneal dystrophies includes Meesmann
dystrophy (MECD), Reis-Bücklers corneal dystrophy
(RBCD), Thiel-Behnke dystrophy (TBCD), gelatinous
drop-like corneal dystrophy (GDCD), Lisch epithelial cor-
neal dystrophy (LECD), epithelial recurrent erosion dys-
trophy (ERED) and subepithelial mucinous corneal
dystrophy (SMCD).
Epidemiology
The prevalence of the different superficial corneal dystro-
phies is unknown, but all are rare and found mainly in
populations containing the responsible mutated gene.
MECD has been recognized in Denmark, Germany, Japan,
USA, Saudi Arabia and Poland [5]. TBCD has been recog-
nized in Germany, the USA and in other countries. GDCD
have been reported in patients from India, Tunisia, Viet-
nam, Turkey, the USA and other countries, but most cases
seem to be in Japan where the disorder is estimated to 1
in ~300,000 persons [6]. LECD has only been docu-
mented in one German family and in rare sporadic cases
in Germany and the USA. SMCD has only been docu-
mented in one family of Slovak descent.
Etiology
Like the other corneal dystrophies, those of the superficial
cornea are genetically determined and usually inherited as
Mendelian traits. The unique phenotypes of the vast
majority of corneal dystrophies are caused by mutations
in different specific genes. The phenotype of some corneal
dystrophies result from mutations in different genes and
different phenotypes may be the result of different muta-
tions in the same gene. Mutations in four genes (KRT3,
KRT12,  TGFBI, and TACSTD2) are currently known to
cause inherited diseases that are apparently limited to the
superficial cornea.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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Clinical description, histopathologic findings, etiology, management
Meesmann dystrophy (MECD, Stocker-Holt dystrophy, MIM 
#122100)
Meesmann dystrophy is characterized by distinct tiny
bubble-like, round-to-oval punctate opacities that form in
the central corneal epithelium and to a lesser extent in the
peripheral cornea of both eyes during infancy [7-9] (Fig-
ure 1). These opacities caused by intraepithelial cysts
appear as transparent dew drops in retroillumination and
they are extremely difficult to see without slit lamp biom-
icroscopy (Figure 2). They usually fail to stain after topi-
cally applied fluorescein because they seldom open to the
surface. MECD often remains asymptomatic until about
middle age, when, intermittent, mild ocular irritation,
photophobia, transient blurred vision, and irregular astig-
matism develop. At that time, the entire corneal epithe-
lium contains the intraepithelial opacities with some
breaking through the epithelial surface. In severe cases,
subepithelial scarring produces a slight grayish central
corneal opacification. Corneal sensitivity is normal.
Table 1: Summary of the corneal dystrophies: modes of inheritance, gene loci, genes and the categories of the International 
Committee for the Classification of Corneal Dystrophies (IC3D) categories
Mode of inheritance Gene locus Gene IC3D Category*
SUPERFICIAL CORNEAL DYSTROPHIES
Meesmann dystrophy AD 12q13 KRT3 1
Meesmann dystrophy AD 17q12 KRT12 1
Stocker-Holt dystrophy AD 17q12 KRT12 1
Granular corneal dystrophy type III
(Reis-Bücklers dystrophy) AD 5q31 TGFBI 1
Thiel-Behnke dystrophy AD 5q31 TGFBI 1
Thiel-Behnke dystrophy AD 10q23–q24 Unknown 2
Gelatinous droplike corneal dystrophy (familial subepithelial 
corneal amyloidosis)
AR 1p32 TACSTD2 (M1S1) 1
Subepithelial mucinous corneal dystrophy AD Unknown Unknown 4
Lisch epithelial dystrophy XR Xp22.3 Unknown 2
Epithelial recurrent erosion dystrophy AD Unknown Unknown 3
CORNEAL STROMAL DYSTROPHIES
Macular corneal dystrophy AR 16q22 CHST6 1
Granular corneal dystrophy type I AD 5q31 TGFBI 1
Granular corneal dystrophy type II
(Avellino dystrophy,
combined lattice-granular dystrophy) AD 5q31 TGFBI 1
Lattice corneal dystrophy type I and variants AD 5q31 TGFBI 1
Lattice corneal dystrophy type II AD 9q34 GSN 1
Fleck dystrophy AD 2q35 PIP5K3 1
Schnyder corneal dystrophy AD 1p34.1–p36 UBIAD1 1
Posterior amorphous corneal dystrophy AD Unknown Unknown 3
Congenital stromal dystrophy AD 12q13.2 DCN 1
POSTERIOR DYSTROPHIES
Fuchs dystrophy (early onset) AD 1p34.3 COL8A 1
Fuchs dystrophy (late onset) AD 13pTel-13q12.13 Unknown 2
Fuchs dystrophy (late onset) AD 18q21.2–q21.32 Unknown 2
Fuchs dystrophy (late onset) ? 20p13-p12 SLC4A11 1
Fuchs dystrophy (late onset) ? 10p11.2 TCF8 1
Posterior polymorphous dystrophy type 1 AD 20p11.2 Unknown 2
Posterior polymorphous dystrophy type 2 AD 1p34.3-p32.3 COL8A2# 1
Posterior polymorphous dystrophy type 3 AD 10p11.2 TCF8 1
Congenital endothelial dystrophy type 1 AD 20p11.2-q11.2 Unknown 2
Congenital endothelial dystrophy type 2
AR 20p13-p12 SLC4A11 1
X-linked endothelial corneal dystrophy XR Unknown Unknown 2
* Category 1: A well-defined corneal dystrophy in which the gene has been mapped and identified and specific mutations are known
Category 2: A well-defined corneal dystrophy that has been mapped to 1 or more specific chromosomal loci, but the gene(s) remains to be 
identified
Category 3: A well-defined clinical corneal dystrophy in which the disorder has not yet been mapped to a chromosomal locus.
Category 4: A suspected new, or previously documented corneal dystrophy, although the evidence for it, being a distinct entity, is not yet 
convincing.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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Table 2: Summary of the Clinical Features of the Corneal Dystrophies
Disease onset Visual acuity Clinical appearance of cornea on 
slit-lamp biomicroscropy
SUPERFICIAL CORNEAL 
DYSTROPHIES
MECD Early childhood Vision rarely blurred Multiple distinct epithelial vesicles
RBCD Childhood Progressive visual impairment Confluent irregular geographic 
opacities in Bowman layer and 
superficial stroma
TBCD First/second decade Progressive visual impairment Subepithelial honeycomb opacities 
in central superficial cornea
GDCD First/second decade Marked visual impairment Subepithelial nodular deposits and 
late staining of fluorescein
LECD Childhood Sometimes impaired Epithelial opacities in different 
patterns
ERED First decade Sometimes impaired Epithelial erosions
SMCD First decade Progressive loss of vision Subepithelial opacities
CORNEAL STROMAL 
DYSTROPHIES
MCD Usually childhood Eventually severe visual 
impairment
Thinner than normal cornea with 
diffuse corneal haze with irregular 
shaped whitish opacities
GCD type I Childhood Progressive visual impairment Well-defined granules that 
sometimes resemble crushed 
bread crumbs within a crystal clear 
cornea
GCD type II First/second decade Progressive impairment of vision Variable shaped opacities in a clear 
superficial mid stroma of the 
cornea. Lattice lines sometimes 
appear in deeper cornea
LCD type I and variants First decade Progressive visual impairment Delicate branching interwoven 
linear opacities occur in 
association with ovoid dots
LCD type II Third/fourth decade Vision usually normal until sixth 
decade
Corneal opacities forming lattice 
lines are found mainly in the 
peripheral cornea
FCD At birth Normal small discrete dandruff or ring 
shaped, fleck like opacities
SCD Early in life Progressive decrease in visual 
acuity
Central corneal haze or 
subepithelial crystals
CSCD Before birth Moderate to severe visual loss Diffuse corneal clouding with flake-
like opacities throughout stroma
PACD Infancy or childhood Mildly affected Diffuse sheet-like opacities 
especially in posterior corneal 
stroma
POSTERIOR DYSTROPHIES
FECD Variable but usually fourth decade 
or later
Progressive visual impairment Diffuse thickening of Descemet 
membrane with excrescences 
(guttae). Endothelial cells sparse 
and atrophic
PPCD Early childhood Rarely progressive visual 
impairment
Variable shaped abnormalities of 
the corneal endothelium
CHED1 Occasionally at birth, but usually in 
first/second decade
Blurred vision that worsens in the 
morning
Thickened cornea with diffuse 
clouding with occasional focal gray 
spots
CHED2 At birth Blurred vision Thickened cornea with diffuse 
clouding with occasional focal gray 
spots
XECD At birth Blurred vision common in males Cloudy cornea (only in males) with 
moon crater-like endothelial cellsOrphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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Histopathologically, MECD is characterized by intraepi-
thelial cysts at different levels in the corneal epithelium,
which is irregular in thickness. Degenerated cellular debris
within the intraepithelial microcysts manifests autofluo-
rescence in ultraviolet (UV) light and it stains with the
Hale colloidal iron technique for negatively charged sub-
stances such as glycosaminoglycans (GAGs) [10-13]. It is
also periodic acid-Schiff (PAS)-positive and diastase- and
neuraminidase-resistant [11]. The epithelial basement
membrane is variably thickened, but this is a common
nonspecific finding in many disorders of the corneal epi-
thelium. Bowman layer and the corneal stroma are unre-
markable. Transmission electron microscopy (TEM)
discloses focal aggregations of electron dense fibrillogran-
ular keratin within the cytoplasm of the corneal epithe-
lium (the "peculiar substance" of Kuwabara and
Ciccarelli) [12], which is surrounded by cytoplasmic fila-
ments and vacuoles (Figures 3 and 4).
MECD is caused by a mutation in either one of the pair of
genes (KRT3  or  KRT12) that encode the two units of
cytokeratin in the corneal epithelium [14-18]. The muta-
tions have been in extremely conserved keratin boundary
motifs. For example, in cytokeratin 12 they involve the
helix termination or initiation motif. Dominant muta-
tions affecting this part of the molecule in other keratins
severely impair cytoskeletal function. The epithelial cells
normally become displaced to the surface of the cornea
discharging the defective cells and cysts. Stocker-Holt cor-
Meesmann corneal dystrophy Figure 1
Meesmann corneal dystrophy. Multiple opaque spots in 
the corneal epithelium.
Meesmann corneal dystrophy Figure 2
Meesmann corneal dystrophy. Cornea viewed by retroil-
lumination showing numerous small spots.
Meesmann corneal dystrophy Figure 3
Meesmann corneal dystrophy. Transmission electron 
micrograph of the corneal epithelium showing clusters of 
electrodense fibrillogranular material within a degenerated 
epithelial cell.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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neal dystrophy [19,20] is a variant of MECD caused by a
p. Arg19Leu amino acid change in the cytokeratin 12 [21].
MECD persists throughout life. Removal of the abnormal
corneal epithelium has been used as a treatment modal-
ity, but it is not curative. Even with removal of the patho-
logic epithelium, this dystrophy recurs in the regenerated
epithelium.
Reis-Bücklers corneal dystrophy (RBCD, corneal dystrophy of 
Bowman layer type I, geographic corneal dystrophy, superficial 
granular corneal dystrophy (GCD), atypical GCD, GCD type III, 
anterior limiting membrane dystrophy type I, MIM #608470)
Symmetrical reticular opacities form in the superficial
central cornea of both eyes at about 4–5 years of age in
RBCD a corneal disorder that was first described by Reis
[22] and later by Bücklers [23] (Figure 5). The opacities
assume an irregularly ring-shaped pattern of discrete spots
and lines that focally elevate the corneal epithelium.
RBCD remains asymptomatic until epithelial erosions
precipitate acute episodes of ocular hyperemia, pain, and
photophobia. Visual acuity eventually becomes reduced
during the second and third decades of life following a
progressive superficial haze and an irregular corneal sur-
face. RBCD becomes symptomatic earlier and with a
higher frequency of recurrent erosions than patients with
other variants of GCD. The superficial corneal stroma in
RBCD contains deposits of mutated transforming growth
factor beta induced protein that are indistinguishable
from those of various forms of GCD [24-27] (Figures 6
and 7), hence the synonym GCD type III.
All well-documented cases of RBCD are caused by a spe-
cific mutation in the TGFBI gene (p. Arg124Leu). Haplo-
Meesmann corneal dystrophy Figure 4
Meesmann corneal dystrophy. Higher magnification 
transmission electron micrograph of the characteristic pecu-
liar substance (Ps) that is composed of mutated cytokeratin. 
It is evident in close association with individual filaments (F) 
(Reproduced with permission from Fine et al.[11]).
Reis-Bücklers corneal dystrophy Figure 5
Reis-Bücklers corneal dystrophy. Reticular opacity in the 
superficial cornea.
Reis-Bucklers corneal dystrophy Figure 6
Reis-Bucklers corneal dystrophy. Light microscopic view 
of abnormal deposit of fuschinophic mutated transforming 
growth factor beta induced protein in the superficial corneal 
strome. Masson trichrome stain (Courtesy of Dr. Guy S. 
Allaire).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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type analyses of different families have provided evidence
of multiple origins of this mutation. Other mutations in
the TGFBI gene have been reported in subjects alleged to
have RBCD or an atypical variant (p. Gly623Asp) based
on the clinical recognition of geographic opacities in the
anterior to mid corneal stroma, but without histopatho-
logic confirmation [28]. Some of these cases may have
TBCD, which is impossible to differentiate from RBCD
without transmission electron microscopy (TEM) of the
affected cornea [29,30]. The RBCD phenotype has been
detected in Sardinians with a Δ F540 mutation in TGFBI
without histopathologic confirmation [31]. Reports of a
p. Arg555Gln mutation in TGFBI in patients alleged to
have RBCD are unacceptable because these individuals
were not characterized by appropriate typical light micro-
scopic and TEM findings [1].
In RBCD a progressive deterioration of vision follows ocu-
lar discomfort and pain from recurrent epithelial erosions
and the condition remains symptomatic in the absence of
therapy. In advanced cases of RBCD, a superficial keratec-
tomy, phototherapeutic keratectomy (PTK) or lamellar
keratoplasty (LKP) may improve vision, but a penetrating
keratoplasty (PK) is rarely necessary because the patho-
logic changes only involve the superficial cornea.
Thiel-Behnke dystrophy (TBCD, corneal dystrophy of Bowman layer 
type II, honeycomb corneal dystrophy, anterior limiting membrane 
dystrophy type II, curly fibers corneal dystrophy, Waardenburg-
Jonker corneal dystrophy, MIM %602082)
In this type of corneal dystrophy, sub-epithelial corneal
opacities form a honeycomb-shaped pattern in the super-
ficial cornea [32]. A clear zone is present at the corneoscle-
ral limbus. Corneal erosions start in the first and second
decade and cause ocular discomfort and pain. The ero-
sions recur and vision gradually becomes impaired.
On histology, the corneal epithelium varies in thickness
and contains nonspecific degenerative changes. The epi-
thelial basal lamina and Bowman layer display variable
degenerative changes. There is also irregular subepithelial
collagenous tissue. TEM discloses pathognomonic short,
curled filaments measuring (about 8–10 nm in diameter)
interspersed among normal collagen fibrils in Bowman
zone and the contiguous superficial corneal stroma [33].
In advanced stages of TBCD, the anterior stromal collagen
and Bowman layer may be markedly disorganized and
replaced by numerous aggregates of these filaments. His-
topathologically, subepithelial fibrous tissue accumulates
in a wave-like configuration. The characteristic subepithe-
lial "curly" fibers can only be identified by TEM. Laminin
and bullous pemphigoid antigen have been localized in a
piebald mosaic distribution within the aberrant subepi-
thelial fibrous tissue suggesting a primarily epithelial dis-
ease with the peculiar curly material paralleling the
distribution of attachment proteins. Except for abnormal-
ities in the superficial cornea the remainder of the cornea
is unremarkable.
TBCD has an autosomal dominant mode of inheritance
and was mapped to chromosome 5 (5q31). It was later
found to be associated with a p. Arg555Gln mutation in
TGFBI [29,34], which may be diagnostic, but more fami-
lies with the characteristic ultrastructural abnormalities
need to be documented to establish this with certainty.
Many reports documenting the p. Arg555Gln mutation in
the TGFBI gene have based the diagnosis solely on the
clinical phenotype and have not taken into account the
necessary requirement of a tissue diagnosis. Genetic heter-
ogeneity seems to exist and another locus for TBD has also
been identified on chromosome 10 (10q23–q24) [35].
Like many other inherited corneal disorders TBCD may
recur in the graft following therapeutic methods that
ablate the abnormal cornea.
Gelatinous drop-like corneal dystrophy (GDCD, subepithelial 
amyloidosis, primary familial amyloidosis, MIM #204870)
Multiple prominent milky-white gelatinous mulberry-
shaped nodules form beneath the corneal epithelium dur-
ing the first decade of life GDCD [36,37] (Figures 8 and
Reis-Bücklers corneal dystrophy Figure 7
Reis-Bücklers corneal dystrophy. Light microscopy of 
cornea showing characteristic red stained deposits of 
mutated transforming growth factor beta induced protein in 
the superficial corneal stroma. In this specimen they extend 
deeper into the corneal stroma than the abnormal deposits 
of Figure 6. Masson trichrome stain.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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9). Other features are severe photophobia, tearing, a cor-
neal foreign body sensation and a severe progressive loss
of vision. Fusiform deposits similar to those in lattice cor-
neal dystrophy (LCD) may also form in the deeper
stroma. In GDCD multiple nodules of amyloid deposit in
the subepithelial corneal tissue of both corneas (Figures
10 to 12). The amyloid contains lactoferrin, but the dis-
ease is not linked to the lactoferrin gene [38].
More than 20 mutations in the TACSTD2 (formerly M1S1,
TROP2, GA733-1) gene that encodes tumor-associated
calcium signal transducer 2 (gastrointestinal tumor-asso-
ciated antigen 1) cause GDCD. The p. Gln118X mutation
has been detected most often. Some affected individuals
have been found not to have mutations in TACSTD2 sug-
gesting the existence of genetic heterogeneity in this auto-
somal recessive disease [39].
In GDCD, the response to both LKP and PK as well as to
a superficial keratectomy is unsatisfactory as amyloid
recurs in the graft within about 5 years.
Lisch epithelial corneal dystrophy (LECD, band-shaped and whorled 
microcystic dystrophy of the corneal epithelium)
LECD is characterized by feather shaped opacities and
microcysts in the corneal epithelium that are arranged in
a band-shaped and sometimes whorled pattern. Painless
blurred vision sometimes begins after sixty years of life
Gelatinous drop-like corneal dystrophy Figure 8
Gelatinous drop-like corneal dystrophy. A completely 
opaque cornea with multiple drop-like nodular opacities. 
Some blood vessels are present in the opaque cornea.
Gelatinous drop-like corneal dystrophy Figure 9
Gelatinous drop-like corneal dystrophy. Recurrent 
drop-like deposits of subepithelial amyloid are present in the 
donor tissue of a corneal graft as well as in the surrounding 
host tissue.
Gelatinous drop-like corneal dystrophy Figure 10
Gelatinous drop-like corneal dystrophy. Light micros-
copy of subepithelial deposit of amyloid. Hematoxylin and 
eosin stain.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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[40,41]. The corneal epithelium has a bubbly vacuoliza-
tion with optically empty spaces.
The epithelial cells in parts of the cornea that correspond
to the clinically evident whorl-like opacity have a diffuse
cytoplasmic vacuolization. By TEM, the vacuoles are
mainly empty but contain scant nonspecific osmiophilic
material [40,42,43]. The identity of the content of the vac-
uoles remains unknown.
The gene for LECD has been mapped to the short arm of
the X chromosome (Xp22.3) at a maximum likelihood of
odds (LOD) score of 2.93 [41]. As expected because of the
mode of inheritance it is not linked to the KRT3  and
KRT12 genes.
The epithelial opacities are slowly progressive and may
lead to visual deterioration in LECD. Cellular debride-
ment of the corneal epithelium has been tried as a thera-
peutic modality, but after this treatment LECD recurs.
Epithelial recurrent erosion dystrophy (ERED, recurrent hereditary 
corneal erosions, Dystrophia Helsinglandica, Dystrophia 
Smolandiensis, MIM %122400)
This type of corneal dystrophy is characterized by recur-
rent episodes of epithelial erosions from childhood in the
absence of associated diseases [44-48]. The erosions begin
spontaneously or are precipitated by minor trauma, dust
or smoke. The condition may become apparent by 6
months of age, but as a rule it only starts at 4 to 6 years of
age. The erosions may be accompanied by a subepithelial
haze or blebs and subepithelial opacities, apparently due
to fibrosis or keloid-like nodules may develop.
Specific morphologic abnormalities have not been identi-
fied in ERED.
The etiology is not completely understood. The gene for
ERED remains to be mapped to a specific chromosomal
locus.
ERED can be treated medically with effort devoted
towards healing the epithelial defect and protecting the
loosely adherent epithelium. A topical antibiotic,
cycloplegic and pressure patch are valuable. A lubricating
ointment is useful at night. Hypertonic saline and band-
age contact lens therapy may also have a role.
In ERED the intensity and frequency of the recurrent epi-
thelial erosions tend to diminish with time and usually
cease by the end of the fourth decade. When present, sub-
epithelial opacities continue to enlarge.
Subepithelial mucinous corneal dystrophy (SMCD)
Frequent recurrent corneal erosions in the first decade of
life characterizes SMCD and in the only publication on
this condition older individuals developed subepithelial
opacities and a corneal haze [49] (Figures 13 and 14).
A striking morphologic feature of corneal tissue with
SMCD is the presence of subepithelial mucinous material.
It is associated with a band in Bowman layer of GAGs that
have been identified as chondroin-4-sulfate and dermatan
sulfate histochemically (Figures 15 to 17).
Gelatinous drop-like corneal dystrophy Figure 11
Gelatinous drop-like corneal dystrophy. Light micros-
copy view of subepithelial deposit of amyloid. Congo red 
stain.
Gelatinous drop-like corneal dystrophy Figure 12
Gelatinous drop-like corneal dystrophy. Apple green 
dichroism of subepithelial deposition of amyloid viewed 
under polarized light. Congo red stain.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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The gene for SMCD has not been mapped to a particular
chromosomal locus.
Initially when recurrent epithelial erosions of the cornea
are present, treatment can be as in ERED (see above). As
this dystrophy has only been reported in one family only,
the ideal therapy remains uncertain. SMCD eventually
progresses over time leading to corneal opacities.
Differential diagnosis
MECD needs to be differentiated from other disorders of
the corneal epithelium, such as vapor spray keratitis, mild
epithelial edema and the bleb pattern of epithelial base-
ment membrane dystrophy. MECD and LECD have clini-
cal similarities and need to be distinguished from each
other and this easily done by the different modes of inher-
itance. TBCD has similarities to RBCD, but perhaps has a
less severe clinical course; without a tissue examination or
molecular genetic analysis TBCD is commonly misdiag-
nosed as RBCD. ERED needs to be differentiated from
other conditions that are accompanied by recurrent epi-
Subepithelial mucinous corneal dystrophy Figure 13
Subepithelial mucinous corneal dystrophy. An irregu-
lar shaped opacity is present in the superficial cornea. 
(Reproduced with permission from Feder et al.[48]).
Subepithelial mucinous corneal dystrophy Figure 14
Subepithelial mucinous corneal dystrophy. A diffuse 
haziness is present in the papillary region of the cornea in 
association with discrete opacities. (Reproduced with per-
mission from Feder et al.[48]).
Subepithelial mucinous corneal dystrophy Figure 15
Subepithelial mucinous corneal dystrophy. The region 
of cornea beneath the epithelium, where Bowman layer is 
normally present, contains an intensely stained band. Alcian 
blue stain. (Reproduced with permission from Feder et 
al.[48]).
Subepithelial mucinous corneal dystrophy Figure 16
Subepithelial mucinous corneal dystrophy. The subepi-
thelial mucoid material stains a lighter green than Bowman 
layer and the corneal stroma. Masson trichrome stain. 
(Reproduced with permission from Feder et al.[48])Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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thelial erosions, particularly when they are the initial pre-
senting manifestations early in life, such as epithelial
basement membrane dystrophy, MECD, RBCD, TBCD,
SMCD, LCD1, GCD1, GCD2, and MCD. In the only man-
uscript on SMCD, a diagnosis of Grayson-Wilbrandt cor-
neal dystrophy was considered, but the precise nature of
the latter condition remains unknown.
Management including treatments
Patients with superficial corneal opacities are suitable can-
didates for a superficial keratectomy, lamellar kerato-
plasty or phototherapeutic keratectomy. Superficial
corneal dystrophies do not need a penetrating kerato-
plasty as the deeper corneal tissue is unaffected.
B. Corneal stromal dystrophies
This group of corneal dystrophies includes macular cor-
neal dystrophy (MCD), granular corneal dystrophy
(GCD) type I, the lattice corneal dystrophies (LCD),
Schnyder corneal dystrophy (SCD), fleck corneal dystro-
phy (FCD), congenital stromal corneal dystrophy (CSCD)
and posterior amorphous corneal dystrophy (PACD).
Clinical description, histopathologic findings, etiology, management
Macular corneal dystrophy (MCD, corneal dystrophy Groenouw type 
II, Fehr corneal dystrophy, MIM #217800)
Ill-defined cloudy regions usually first appear within a
hazy stroma of both corneas during adolescence, but the
opacities may become apparent in early infancy or as late
as the sixth decade (Figure 18). Over time, the non-trans-
parent areas progressively merge as the entire corneal
stroma gradually becomes cloudy, causing severe visual
impairment usually before the fifth decade. The bilateral
corneal opacities progressively extend through the entire
thickness of the central and peripheral corneal stroma.
The corneal stroma is thinner than normal. Most patients
with MCD do not have detectable keratan sulfate in the
serum (MCD types I and IA), but in some have normal
antigenic keratan sulfate levels in the serum (MCD type II)
[50-53]. These immunophenotypes can not be distin-
guished from each other clinically and are of no clinical
significance.
MCD has been identified throughout the world, but in
most populations it is rare. It is most prevalent in India,
Saudi Arabia, Iceland and parts of the USA. At one time
MCD was the most frequent indication for a penetrating
keratoplasty in Iceland [54].
Despite its traditional inclusion as a stromal dystrophy in
classifications of the corneal dystrophies, MCD involves
Descemet membrane and the corneal endothelium in
addition to the corneal stroma. The histopathology of
MCD is characteristic. Intracytoplasmic accumulations
occur within the keratocytes and corneal endothelium,
but the corneal epithelium is spared. The accumulations
stain positively with histochemical stains for gly-
cosaminoglycans, such as periodic acid-Schiff, alcian blue,
metachromatic dyes, and possess an affinity for colloidal
iron [55] (Figure 19). The accumulations also stain with
the periodic acid-Schiff/thiocarbohyrazide/silver protein-
ate and the periodic acid-methenamine silver techniques.
Intracytoplasmic vacuoles are a distinct ultrastructural fea-
Subepithelial mucinous corneal dystrophy Figure 17
Subepithelial mucinous corneal dystrophy. Transmis-
sion electron microscopic view showing relatively lucent area 
with fine filaments adjacent to collagen fibers and a kerato-
cyte. (Reproduced with permission from Feder et al.[48])
Macular corneal dystrophy Figure 18
Macular corneal dystrophy. Discrete opacities are 
present within hazy cornea that lacks areas of normal clarity.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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ture of the keratocytes and with appropriate tissue fixation
delicate fibrillogranular material can be discerned within
the vesicles (Figures 20 to 22). Some corneal endothelial
cells contain similar material (Figures 23 to 25). Numer-
ous electron-lucent lacunae are randomly distributed
throughout corneas and some lacunae are filled with clus-
ters of abnormal sulfated chondroitinase ABC non-sus-
ceptible proteoglycan filaments.
The collagen fibrils have a normal diameter, but the inter-
fibrillar spacing of collagen fibrils in affected corneas is
less than that in the normal cornea. This close packing of
collagen fibrils seems to be responsible for the reduced
Macular corneal dystrophy Figure 19
Macular corneal dystrophy. The abnormalities within the 
cornea are easily seen within the keratocytes and in a subep-
ithelial extracellular location because they stain prominently 
with methods that demonstrate glycosaminoglycans. Hale 
colloidal iron stain.
Macular corneal dystrophy Figure 20
Macular corneal dystrophy. Transmission electron 
micrograph of the corneal stroma showing remnant of a 
keratocyte distended with fibrillogranular material and cellu-
lar debris. Some extracellular debris is also present amongst 
the collagen lamellae (Reproduced with permission from 
Klintworth [2]).
Macular corneal dystrophy Figure 21
Macular corneal dystrophy. Transmission electron 
micrograph of the cytoplasm of a keratocyte showing fibrillo-
granular material within membrane bound tubules.
Macular corneal dystrophy Figure 22
Macular corneal dystrophy. Scanning electron micro-
graph of a section through the corneal stroma showing an 
accumulation of abnormal material between the collagen 
lamellae in the location of a keratocyte.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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corneal thickness in MCD. The anterior banded portion of
Descemet membrane which forms in utero is of normal
thickness and has an unremarkable ultrastructure,
whereas the posterior layer usually contains numerous
corneal guttae. The latter, together with intervening parts
of the posterior layer of Descemet membrane, are studded
with numerous vacuoles giving a honeycombed appear-
ance (Figure 26). The electron-lucent areas presumably
contained extracellular deposits of GAGs which dissolved
during tissue processing. The stroma of MCD corneas con-
tains congregations of various sized cuprolinic blue
stained filaments which vary both in size and in electron
density. Histopathologically, MCD is typified by an intra-
cellular storage of glycosaminoglycans (GAGs) within
keratocytes and the corneal endothelium combined with
an extracellular deposition of similar material in the cor-
Macular corneal dystrophy Figure 23
Macular corneal dystrophy. Scanning electron micro-
graph of the corneal endothelium showing the surface pro-
files of the nuclei as well as numerous much smaller nodules 
caused by cytoplasmic accumulations of glycosaminoglycans 
within the corneal endothelium (Reproduced with permis-
sion from Klintworth [1]).
Macular corneal dystrophy Figure 24
Macular corneal dystrophy. Transmission electron 
micrograph of the deep corneal stroma, Descemet mem-
brane and the corneal endothelium. This portion of the cor-
neal endothelium contains fibrillogranular material within 
numerous vacuoles and a distinct vacuolated band is evident 
in Descemet membrane beneath the most posterior part of 
this layer.
Macular corneal dystrophy Figure 25
Macular corneal dystrophy. Higher magnification trans-
mission electron micrograph of the corneal endothelium and 
Descemet membrane. Note that part of Descemet mem-
brane is associated with small vacuoles and containing osmi-
ophilic material and that the electron density of the portion 
of Descemet membrane immediately adjacent to the 
endothelium is variable (Reproduced with permission from 
Klintworth [1]).
Macular corneal dystrophy Figure 26
Macular corneal dystrophy. Scanning electron micro-
graph through a part of Descemet membrane showing a hon-
eycomb appearance due to spaces where abnormal material 
was lost during tissue processing.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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neal stroma and Descemet membrane. Guttae are com-
mon on Descemet membrane. Numerous electron-
transparent lacunae are randomly distributed throughout
MCD corneas. The collagen fibrils have a normal diameter
but their packing differs between specimens.
Three immunophenotypes of MCD are recognized
[51,53,56]: one has no detectable keratan sulfate (KS) in
the serum or cornea (MCD type I) (Figures 27 and 28),
another has normal amounts of KS in the serum and cor-
nea (MCD type II) (Figure 29) and a third lacks detectable
antigenic keratan sulfate in the serum, but has stainable
KS in the keratocytes (MCD type IA). While deposits sim-
ilar to those in the cornea have not been noted in carti-
lage, the chondrocytes and extracellular matrix of the
nasal cartilage do not react with a monoclonal antibody
against a sulfated epitope on KS and the KS content of the
cartilage is at least 800 times lower normal. Patients with
MCD whose corneas fail to react with anti-KS antibodies
also lack detectable corneal KS, while those with immu-
nohistochemically detectable KS have normal levels of
serum KS.
Mutations in the CHST6 gene are responsible for most
cases of MCD [57,58], but all cases of MCD can not be
explained by mutations in the coding region of CHST6, by
major deletions or insertions in the upstream region, or
by splice site mutations which create or destroy signals for
exon-intron splicing [59]. Marked allelic heterogeneity in
CHST6 has been documented in different populations
throughout the world. The most frequent abnormalities
are missense and nonsense single nucleotide polymor-
phisms (SNPs) in CHST6 that alter a conserved amino
acid. Insertional or deletional defects in the region
between the CHST5 and CHST6 genes account for some
cases. More than 125 CHST6 mutations have been identi-
fied in subjects with MCD from different countries (Brit-
ain, France, Iceland, India, Italy, Japan, Saudi Arabia, USA,
and Vietnam) [4,59]. Heterozygous mutations have been
detected in exon 3 of CHST6 in most families and almost
all of them are associated with another heterozygous
mutation in the coding region of CHST6 on the other
chromosome. Other MCD causing mutations are nucle-
otide insertions or deletions in the coding region of
CHST6 that cause frameshift changes as well as a few dele-
tions or substitutions upstream between CHST5 and
CHST6. The molecular basis for the different immu-
nophenotypes remains to be determined and a molecular
genetic study of MCD in Saudi Arabia found identical
CHST6 mutations in families with MCD type I, IA and II
[60]. A recent study has recognized several atypical immu-
Macular corneal dystrophy Figure 27
Macular corneal dystrophy. Light microscopic view of a 
corneal graft in a patient with MCD type I (left side of image) 
showing a normal brown reactivity of the corneal stroma to 
the anti-keratan sulfate antibody. The host tissue with MCD 
type I (right side of image) does not stain. Immunoperoxidase 
stain with antikeratan sulfate antibody.
Macular corneal dystrophy type I Figure 28
Macular corneal dystrophy type I. In contrast to MCD 
type II (see Figure 29) the corneal deposits do not exhibit 
antigenic keratan sulfate and hence do not react with anti-
bodies to keratan sulfate. Immunoperoxidase stain with anti-
keratan sulfate antibody.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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nophenotypes and found no relationship to specific
mutations in CHST6 [61].
In MCD, vision can be restored by corneal grafting in
MCD, but the disease may recur in the graft after many
years. Because the condition affects the entire corneal
stroma, Descemet membrane and the corneal endothe-
lium a lamellar keratoplasty will not excise all of the path-
ologic tissue.
Granular corneal dystrophy (GCD) type I (classic GCD, corneal 
dystrophy Groenouw type I, MIM #121900)
Multiple small white discrete irregular-shaped sharply
demarcated spots that resemble bread crumbs or snow-
flakes become apparent beneath Bowman zone in the
superficial central corneal stroma (Figures 30 and 31).
They initially appear within the first decade of life and
may be evident by 3 years of age. The opaque spots are
often arranged in lines and with time they gradually
enlarge and become more numerous. In children the
external corneal surface is smooth, but in adults it often
becomes uneven. While some patients have only a few
corneal granules, others eventually have many and the
cornea becomes markedly opaque. Visual acuity is more
or less normal. By the end of a second decade, many opac-
ities are present in the central and superficial cornea but
rarely in the deep stroma. Intervening tissue between the
opacities and in the peripheral 2–3 mm of the cornea usu-
ally remains crystal clear. The opaque spots eventually
extend throughout the central two-thirds of the cornea.
The stromal deposits do not move after they form. Subtle
differences in the clinical appearance of the discrete cor-
neal opacities permit two types of GCD to be recognized:
GCD type I (GCD1) and GCD type II (GCD2). GCD2
tends to have fewer corneal deposits that GCD1 and the
Macular corneal dystrophy type II Figure 29
Macular corneal dystrophy type II. The corneal accumu-
lations contain antigenic keratan sulfate and react antibodies 
to keratan sulfate. Immunoperoxidase stain with antikeratin 
sulfate antibody.
Granular corneal dystrophy type I Figure 30
Granular corneal dystrophy type I. Numerous irregular 
shaped discrete crumb-like corneal opacities.
Granular corneal dystrophy type II Figure 31
Granular corneal dystrophy type II. Variable sized 
crumb-like opacities in the corneal stroma that have become 
fused in areas giving rise to elongated and stellate shapes.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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corneal deposits in GCD2 sometimes resemble a combi-
nation of GCD and LCD.
GCD has been extensively studied in Denmark by Møller
[62]. GCD1 seems to be most prevalent in Europe, but
GCD2 is more common in Japan, Korea and the USA. In
Korea GCD2 is estimated to have prevalence of at least
5.52 affected persons/10,000 individuals [Kim EK. Per-
sonal communication 2008, unpublished]. The ancestry
of some families with GCD2 have been traced to the Avel-
lino district of Italy (hence the synonym Avellino corneal
dystrophy).
The corneal opacities in GCD are readily visualized in the
excised cornea (Figure 32). The light microscopic and
TEM appearance and staining attributes of the corneal
deposits in GCD are diagnostic. Eosinophilic lesions
deposit in the cornea in GCD (Figure 33). The corneal
opacities consist predominantly of an extracellular depo-
sition of mutant transforming growth factor beta induced
protein (TGFBIp), which stains a brilliant red with the
Masson trichrome stain [63] (Figures 34 and 35). With the
Wilder reticulin stain, the accumulations contain tangles
of argyrophilic fibers. The deposits react with histochemi-
cal methods for protein as well as with antibodies to TGF-
BIp (Figure 36). The granules stain positively with luxol
fast blue and are reported to stain positively with antibod-
ies to microfibrillar protein.
By TEM characteristic electron dense, discrete, rod-shaped
or trapezoid bodies are evident [64-66] (Figure 37). Cross-
sectional profiles of the corneal deposits are usually irreg-
ularly-shaped, but sometimes hexagonal measuring 100–
500 nm in diameter. Clusters of these elongated bodies
occur particularly in the superficial corneal stroma and
they may be present in the epithelial intercellular space or
within degenerated basal epithelial cells. Some rod-
Granular corneal dystrophy type II Figure 32
Granular corneal dystrophy type II. Photograph of half 
of a surgically excised piece of cornea showing numerous 
irregular shaped white corneal opacities that merge with 
each other.
Granular corneal dystrophy Figure 33
Granular corneal dystrophy. Light microscopy of cornea 
showing abnormal eosinophilic deposits in the corneal 
stroma. Hematoxylin and eosin stain.
Granular corneal dystrophy Figure 34
Granular corneal dystrophy. Light microscopy of irregu-
lar shaped fuchsinophilic (red) deposits in the cornea. Masson 
trichrome stain.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
Page 17 of 38
(page number not for citation purposes)
shaped structures appear homogeneous without a dis-
cernible inner structure; others, however, are composed of
an orderly array of closely packed filaments (70–100 nm
in width) orientated parallel to their long axis, while oth-
ers appear moth-eaten with variable-shaped cavities con-
taining fine filaments (Figure 38). Some superficial and
most deep stromal deposits do not all possess the rod-
shaped configuration. Descemet membrane and the cor-
neal endothelium are unremarkable, and so is the cornea
between the deposits.
Most histopathologically confirmed recurrences have
been superficial to Bowman layer in subepithelial non-
vascularized fibrocollagenous tissue with fibroblasts
almost certainly of host origin. The rare characteristic
deposits within the peripheral stroma of the donor cornea
probably result from an invasion of the graft by corneal
fibroblasts (keratocytes) of the recipient.
GCD usually has an autosomal dominant mode of inher-
itance, but rarely occurs sporadically due to de novo muta-
tions or perhaps even mosaicism. In some families the
mutant gene is completely penetrant, but in others the
penetrance is incomplete. The mutation rate for GCD has
been estimated to be about 0.3/1,000,000 in the Danish
population [67]. Inter-familial differences and intra-
familial similarities occur. When both parents have GCD
their offspring may be homozygous for the TGFBI muta-
tion and develop an unusually severe corneal dystrophy
with larger corneal opacities and an earlier onset than het-
erozygous cases. One family study suggests that persons
heterozygous and homozygous for the TGFBI  gene are
phenotypically identical, but genetic mutations were not
performed in this instance. Numerous mutations in
TGFB1 have been found in clinically and histopathologi-
cally distinct phenotypes, but GCD1 results from a p.
Arg555Trp mutation [68-70], whereas GCD2 is the effect
of a p. Arg124His mutation in the TGFBI gene [71,72].
In most cases of GCD, visual acuity remains good until
late in the course of the disease. After a penetrating kerat-
oplasty, the graft usually remains free of recurrence for at
Granular corneal dystrophy Figure 35
Granular corneal dystrophy. Higher magnification of 
characteristic irregular shaped fuchsinophilic (red) deposit in 
the corneal stroma. Masson trichrome stain.
Granular corneal dystrophy Figure 36
Granular corneal dystrophy. Image of corneal stroma 
showing reactivity of the corneal deposits with an antibody 
to transforming growth factor beta induced protein. Immu-
noperoxidase stain.
Granular corneal dystrophy Figure 37
Granular corneal dystrophy. Characteristic rod-shaped 
bodies in the corneal stroma as seen by transmission elec-
tron microscopy. (Reproduced with permission from Klint-
worth [2]).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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least 30 months, but the opacities may recur in the grafts
within a year, usually superficial to the donor tissue, even
with lamellar grafts, or at the host-graft interface.
Many individuals with GCD never require corneal grafting
because vision is usually not sufficiently impaired. How-
ever, in some cases visual impairment may be marked and
multiple therapeutic procedures may be necessary
because the opacities can recur within after keratoplasty,
sometimes within a year. Until relatively recently, a pene-
trating keratoplasty has been the traditional method for
treating GCD, but postoperative recurrent disease can be
detected in the donor tissue and even along the suture
tracts within several years, particularly in GCD2 [73]. Pho-
totherapeutic keratectomy has been advocated as an ini-
tial therapy for GCD, but recurrent disease is still a
common complication [74]. Since laser-assisted in situ
keratomileusis (LASIK) became popular in the treatment
of myopia, the typical corneal opacities of GCD have been
first become evident following the refractive surgery in
persons with GCD2 [75]. GCD2 may also be exacerbated
by laser epithelial keratomileusis (LASEK) [76]. GCD
(type not determined) has also become manifest after a
radial keratotomy (RK) [77]. LASIK, LASEK and other
forms of refractive surgery are hence contraindicated in
individuals with GCD2.
In most cases of GCD, visual acuity remains good until
late in the course of the disease. After a penetrating kerat-
oplasty, the graft usually remains free of recurrence for at
least 30 months, but the opacities may recur in the grafts
within a year, usually superficial to the donor tissue, even
with lamellar grafts, or at the host-graft interface.
Lattice corneal dystrophies (LCD) type I (Biber-Haab-Dimmer 
dystrophy, MIM #122000)
A network of delicate interdigitating branching filamen-
tous opacities form within the cornea in two genetically
distinct inherited disorders (Figure 39). One with no sys-
temic manifestations is caused by specific mutations in
the TGFBI gene (LCD type I and its variants) (LCD1); the
other resulting from a mutation in the GSN gene (LCD
type II) (LCD2) has systemic manifestations. LCD1 usu-
ally becomes apparent in both eyes towards the end of the
first decade of life, but occasionally it begins in middle life
and rarely in infancy. Linear and other shaped opaque
areas accumulate particularly within the central corneal
stroma, while the peripheral cornea remains relatively
transparent. Corneal sensation is often diminished and
the interwoven linear opaque filaments have some resem-
blance to nerves, but may not be evident in all affected
members of families with LCD1. Recurrent corneal ero-
sions may precede the corneal opacities and even appear
in individuals lacking recognizable stromal disease. Both
corneas are usually symmetrically involved, but some-
times one cornea remains clear or has discrete rather than
linear opacities.
In LCD2 systemic amyloidosis (familial amyloid polyneu-
ropathy type IV, Finnish or Meretoja type; FAP type IV;
Lattice corneal dystrophy type I Figure 39
Lattice corneal dystrophy type I. A network of thick lin-
ear corneal opacities in patient with a variant of LCD1 (LCD 
type III) due to a homozygous p. Leu527Arg mutation in the 
TGFBI gene.
Granular corneal dystrophy Figure 38
Granular corneal dystrophy. Transmission electron 
micrograph showing moth-eaten appearance of extracellular 
corneal concretions in deep corneal stroma (Reproduced 
with permission from Klintworth [2]).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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Meretoja syndrome, MIM #105120) both corneas contain
randomly scattered short fine glassy lines, which are less
numerous, more delicate and more radially oriented than
those in LCD1. The peripheral cornea is chiefly affected
and the central cornea is almost spared. Corneal sensitiv-
ity is reduced. The cornea has fewer amorphous deposits
than LCD1 and epithelial erosions are not a feature. The
condition first becomes apparent after 20 years of age. In
persons homozygous for the relevant mutation in the
GSN gene the disorder begins earlier. Vision does not usu-
ally become significantly impaired before the age of 65
years. LCD2 can be mistaken for LCD1 both clinically and
histopathologically.
The corneal abnormalities are accompanied by a progres-
sive bilateral cranial and peripheral neuropathy, dysar-
thria, a dry and extremely lax itchy skin with amyloid
deposits. A characteristic "mask-like" facial expression,
protruding lips with impaired movement, pendulous ears
and blepharochalasis are also features.
LCD1 is one of the more common corneal dystrophies in
the Western world, but cases have been recognized
throughout the world including Bulgaria [78], Spain [70]
and China [79]. LCD2 is most common in Finland, where
the disease was first discovered and most extensively stud-
ied [80].
Like nerves the linear deposits of LCD1 are argyrophilic
(Figure 40) in silver impregnated preparations, but nerves
have not been identified in relation to the eosinophilic
Lattice corneal dystrophy type I Figure 40
Lattice corneal dystrophy type I. Deposits of amyloid in 
frozen section of the cornea. Lester King stain.
Lattice corneal dystrophy type I variant Figure 41
Lattice corneal dystrophy type I variant. Thicker than 
usual deposits of eosinophilic amyloid in corneal stroma of 
patient with a homozygous p. Leu527Arg mutation in the 
TGFBI gene. Hematoxylin and eosin stain.
Lattice corneal dystrophy type I variant Figure 42
Lattice corneal dystrophy type I variant. Deposits of 
amyloid throughout the corneal stroma due to a p. 
Ala546Asp mutation in the TFGFBI gene in a patient with a 
variant of LCD type 1 (polymorphic corneal amyloidosis). 
(Reproduced with permission from Eifrig et al.[81]).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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amyloid deposits (Figures 41 to 44). Amyloid deposits
occur throughout the corneal stroma [81] and coinciding
with the lattice pattern of lines and other opacities [82].
The amyloid seems to react mainly with antibodies to the
N-terminal sequence of TGFBIp and not with those to the
C-terminal portion [83]. The amyloid in LCD type II is
composed of a mutated 71 amino acid long fragment of
gelsolin and it accumulates in the corneal stroma and
between the epithelium and Bowman layer (Figure 45). In
LCD2 amyloid deposits in the cornea (Figure 46), but also
in scleral, choroidal and adnexal blood vessels as well as
in the lacrimal gland and perineurium of ciliary nerves.
The amyloid is also found in the heart, kidney, skin,
nerves, wall of arteries, and other tissues [84]. The amy-
loid within the cornea in LCD type II reacts with the anti-
gelsolin antibody [85], but not with the antibodies pro-
duced to the amino and carboxy terminals of gelsolin
[86].
TGFBI related lattice corneal dystrophies
The majority of cases of LCD1 throughout the world have
been associated with a C→T transition at nucleotide 417
(417 C→T) in exon 4 of the TGFBI gene. This causes a p.
Arg124Cys mutation in the affected codon [69,70,87].
GSN related lattice corneal dystrophy
Two single base substitutions in the GSN gene, located on
human chromosome 9 (9q34), which encodes the actin-
modulating protein gelsolin are known to cause LCD2 (p.
Asp187Asn, p. Asp187Tyr). The mutation in Finnish,
American, Japanese and English families involves a G to A
substitution at nucleotide 654 (codon 187), resulting in
an asparagine-187 variant of gelsolin. In Danish, Czech
Lattice corneal dystrophy type I variant Figure 43
Lattice corneal dystrophy type I variant. The amyloid 
within the corneal stroma from a patient with a homozygous 
p. Leu527Arg mutation in the TGFBI gene viewed under ultra-
violet light after staining the fluorescent dye Thioflavin T.
Lattice corneal dystrophy type I Figure 44
Lattice corneal dystrophy type I. Transmission electron 
microscopic appearance of amyloid in the upper part of this 
image adjacent to collagen fibers. (Reproduced with permis-
sion from Klintworth [1]).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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and French families a G to T transversion in position 654
at codon 187 results in the substitution of tyrosine for
aspartic acid (Figure 45).
A corneal graft may be necessary in LCD1 by 20 years of
age, but is usually not indicated until after the fourth dec-
ade. The outcome of PK is excellent, but amyloid may
deposit in the grafted donor tissue some 2–14 years later.
The corneal lesions in LCD2 rarely warrant a penetrating
keratoplasty, but when performed a neurotrophic persist-
ent epithelial defect may develop. LCD1 is slowly progres-
sive and usually substantial discomfort and visual
impairment occurs before the sixth decade. Recurrent epi-
thelial erosions are common particularly from the first
decade of life.
Schnyder corneal dystrophy (SCD, Schnyder crystalline corneal 
dystrophy, crystalline stromal dystrophy, Schnyder crystalline 
dystrophy sine crystals, hereditary crystalline stromal dystrophy of 
Schnyder, MIM #121800)
SCD usually becomes apparent early in life with corneal
clouding or with crystals within the corneal stroma. Over
time, an initially unremarkable corneal stroma acquires
small white opacities and a diffuse haze (Figure 47). In
approximately 50% of cases, crystals are not evident clin-
ically (Schnyder crystalline dystrophy sine crystals). Typi-
cally, a ring-shaped yellow-white opacity composed of
innumerable fine needle-shaped crystals forms in Bow-
man layer and the adjacent anterior stroma of the central
cornea. The crystals usually remain in the anterior third of
the cornea. The remaining stroma is unremarkable ini-
tially, but with time it may acquire small white opacities
and a diffuse haze. While sometimes appearing dull
white, the crystals are frequently scintillating with varie-
gated red and green hues. The corneal epithelium and
endothelium as well as Descemet membrane are spared.
SCD is usually bilateral, but one eye may become affected
prior to the other.
Most cases of SCD lack an obvious systemic disorder, but
hypercholesterolemia is common (approximately 40% of
the affected patients), and so are associated manifesta-
Lattice corneal dystrophy type II Figure 45
Lattice corneal dystrophy type II. Diagram depicting gel-
solin and the amyloid protein derived from it because of 
mutations in codon 187 of the GSN gene.
Lattice corneal dystrophy type II Figure 46
Lattice corneal dystrophy type II. Black and white light 
micrograph showing deposits of amyloid in cornea. Congo 
red stain (Reproduced with permission from Klintworth [2]).
Schnyder corneal dystrophy Figure 47
Schnyder corneal dystrophy. Crystalline opacities are 
evident in the central cornea (Courtesy Dr. G.N. Foulks).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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tions, such as arcus lipoides (Figure 48) and xanthelasma.
Genu valgum has been documented in < 4% of patients
[88].
The ancestry of four American families with SCD have
been traced to Southwestern Finland [89].
On histology, birefringent cholesterol crystals and associ-
ated neutral fats accumulate within keratocytes and extra-
cellularly, corresponding to the crystals observed
clinically (Figures 49 to 50). The lipid is also present in
Bowman layer, between the superficial corneal lamellae
and dispersed within the stroma midst the collagen fibrils.
The lipid deposits in SCD comprise mainly multilamellar
vesicles containing unesterified cholesterol and phos-
pholipids, with a lesser contribution of cholesteryl ester
lipid droplets [90]. The lipid deposits within the cornea
are predominantly phospholipids and cholesterol (esteri-
fied and unesterified) [90,91]. The predominant phos-
pholipid is sphingomyelin [91]. Apolipoproteins A-I, A-II,
and E are present, but not apolipoprotein B [92]. An
ultrastructural study of a skin biopsy and cultured fibrob-
lasts from an affected person has disclosed lipid contain-
ing membrane-bound spherical vacuoles. Moreover, skin
fibroblasts from one patient showed abnormal cytoplas-
mic deposits that were fluorescent after staining with fili-
pin, a reagent specific for unesterified cholesterol [93].
The above mentioned observations on skin fibroblasts
taken together with a frequent finding of hyperlipidemia
in patients with SCD strongly suggests the presence of a
systemic disorder of lipid metabolism. However, one
study failed to find evidence of lipid deposition in fibrob-
lasts from the conjunctiva or skin in a patient with SCD
[94].
SCD is caused by one of numerous mutations in the
UBIAD1 gene [95,96].
Visual acuity is usually good in SCD and, as a rule, the
course is stationary after childhood, but corneal opacifica-
tion may progress over time and form a dense central disc
shaped corneal opacity. Excellent scotopic vision contin-
ues until middle age, but most affected individuals need a
penetrating keratoplasty before the seventh decade [88].
An opaque disc of corneal crystals or other lipids may
diminish vision sufficiently in both eyes to result in the
need for a corneal graft.
Fleck corneal dystrophy (FCD, Francois-Neetens speckled corneal 
dystrophy, MIM #121850)
FCD is characterized by multiple asymptomatic, non-pro-
gressive symmetric minute opacities disseminated
throughout the corneal stroma. One type of opacity con-
sists of numerous small, oval, round, wreath-like or semi-
Schnyder corneal dystrophy Figure 48
Schnyder corneal dystrophy. The central cornea contains 
crystalline deposits and a prominent opaque ring (annulus 
lipoides) is evident in the peripheral cornea (Courtesy Dr. 
Seymour Brownstein).
Schnyder corneal dystrophy Figure 49
Schnyder corneal dystrophy. Birefringent crystals of cho-
lesterol are evident in the superficial corneal stroma of this 
unfixed portion of frozen cornea examined under polarized 
light. (Courtesy of Dr. M. M. Rodrigues).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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circular-shaped flattened opacities with distinct borders
("flecks") in the central and peripheral cornea with inter-
vening portions of the cornea being normal (Figures 51
and 52). Other opacities resemble snowflakes or clouds
and consist of small grayish aggregations with ill-defined
margins and occur particularly in the central third of the
cornea (central cloudy phenotype). They are less numer-
ous in the anterior and peripheral stroma and are some-
times most dense in the deeper stroma near Descemet
membrane, on which they are occasionally localized.
These seemingly different opacities, which usually involve
both corneas symmetrically, have been observed in the
same family and even in the same individual. Unilateral
cases have been reported. FCD affects males and females
equally and has been observed throughout life and even
in children as young as 2 years. The corneal epithelium,
Bowman layer, and Descemet membrane are unremarka-
ble. Corneal sensation is usually normal.
Corneal tissue with FCD has rarely been examined, but
some keratocytes contain fibrillogranular material within
intracytoplasmic vacuoles or pleomorphic electron-dense
and membranous intracytoplasmic inclusions [97-99].
The stored material reacts positively with alcian blue, col-
loidal iron, Sudan black B and oil red O stains and is par-
tially sensitive to hyaluronidase and β-galactosidase. It
has the histochemical attributes of GAGs and lipids. Extra-
cellular alterations are rare, but foci of broad spaced colla-
gen have been observed. By TEM single membrane-
limited inclusions containing fine granular material are
evident in the affected cells. Some keratocytes contain ple-
omorphic electron-dense and membranous intracytoplas-
mic inclusions.
FCD is due to a mutation in the PIP5K3 gene [100].
FCD is non-progressive, does not affect vision and is usu-
ally asymptomatic and does not require treatment, but
mild photophobia has been reported. In one patient who
underwent a penetrating keratoplasty for keratoconus,
there was no clinical evidence of recurrent FCD within the
donor tissue after a 10 year follow-up [99].
Schnyder corneal dystrophy Figure 50
Schnyder corneal dystrophy. Transmission electron 
micrograph showing numerous electron lucent spaces in the 
cornea caused by dissolved cholesterol crystals (Courtesy of 
Dr. M. M. Rodrigues) (Reproduced with permission from 
Klintworth [2]).
Fleck corneal dystrophy Figure 51
Fleck corneal dystrophy. Appearance of the cornea by 
slit-lamp biomicroscopy (left image) and by confocal micros-
copy (right image) (Courtesy Dr. Charles N. McGhee).
Fleck corneal dystrophy Figure 52
Fleck corneal dystrophy. The cornea contains small fleck-
like opacities and these can be seen by confocal microscopy 
in the inserts. Note the enlarged cell in the lower insert 
(Courtesy Dr. Charles N. McGhee).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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Congenital stromal corneal dystrophy (CSCD, congenital hereditary 
stromal dystrophy, Witschel dystrophy, MIM #610048)
CSCD is a non-progressive disorder characterized by
numerous opaque flaky or feathery clouding of the cor-
neal stroma. The flakes and spots become more numerous
with age and eventually prevent a clinical evaluation of
corneal endothelium (Figure 53). Corneal erosions, pho-
tophobia and corneal vascularization are absent. Some
affected individuals have strabismus or primary open
angle glaucoma.
CSCD is extremely rare; only 4 families have been
reported. One large family of CSCD is known to have
descendants in Germany and France. Affected individuals
with CSCD have been extensively studied in large French
and Norwegian families.
In CSCD, the morphologic abnormalities include a pecu-
liar arrangement of tightly packed lamellae having highly
aligned collagen fibrils of an unusually small diameter
[101,102] (Figure 54). The cornea is of normal thickness
and both Descemet membrane and the corneal endothe-
lium are relatively normal. Nothing is known about the
biochemical alterations, but the abnormally small stro-
mal collagen fibrils and disordered lamellae suggest a dis-
turbance in collagen fibrogenesis.
A Norwegian family with CSCD has a 1 bp deletion in the
DCN gene [101] which encodes the core protein of deco-
rin, whereas another Belgian family has a DCN frame shift
mutation [103].
Posterior amorphous corneal dystrophy (PACD, posterior amorphous 
stromal dystrophy)
PACD is the designation given by Chapel et al. [104] for a
corneal disorder characterized clinically by irregular
"amorphous" sheet-like opacities in the corneal stroma,
predominantly posterior, and Descemet membrane. In
keeping with the current notion that this is a developmen-
tal disorder, the abnormalities have been observed in
infancy and childhood and, in contrast to the traditional
corneal dystrophies, non-corneal manifestations have
been reported including abnormalities of the iris (irido-
corneal adhesions, corectopia, and pseudopolycoria).
Transparent corneal stroma may intervene between opac-
ities, which sometimes indent Descemet membrane and
the corneal endothelium, which may have focal abnor-
malities. Centroperipheral and peripheral forms of PACD
are recognized. The centroperipheral type extends to the
corneoscleral limbus and is accompanied by corneal thin-
ning and a flattened corneal curvature. Visual acuity is
usually minimally impaired.
Families with PACD have been reported in the USA and
apparent isolated cases of this entity have documented in
Britain [105] and Turkey [106].
Insufficient tissue specimens have been examined to char-
acterize the histopathology of PACD. Disorganized poste-
rior stromal collagen lamellae, and an attenuated corneal
endothelium have been observed [104,107]. A zone of
Congenital stromal dystrophy Figure 53
Congenital stromal dystrophy. The cornea is particularly 
opaque in the anterior stroma by slit-lamp biomicroscopy 
(Reproduced with permission from Bredrup et al. [101]).
Congenital stromal dystrophy Figure 54
Congenital stromal dystrophy. Transmission electron 
microscopy of the corneal stroma showing normal collagen 
lamellae separated by abnormal randomly distributed colla-
gen filaments in an electron-lucent extracellular matrix 
(Reproduced with permission from Bredrup et al.[101]).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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collagen fibers may interrupt Descemet membrane
beneath the anterior banded layer.
The chromosomal locus of the gene responsible for the
autosomal dominant PACD has not been determined.
PACD tend to be non-progressive or slowly progressive.
Visual acuity is usually minimally impaired, but may be
severe enough to warrant a penetrating keratoplasty.
Differential diagnosis
Some affected family members with LCD1 may develop a
clinical phenotype that resembles RBCD. The clinical fea-
tures of MECD have been reported in a family with LCD1,
but this study failed to analyze the KRT3 and KRT12 genes
[79]. MCD needs to be differentiated from the systemic
mucopolysaccharidoses (MPSs) (such as mucopolysac-
charidosis type IH and IS) and the mucolipidoses. In con-
trast to the systemic MPSs, abnormal material deposits
between the collagen fibers in the corneal stroma in MCD.
GCD needs to be distinguished from monoclonal gam-
mopathies because histopathologically the lesions may be
very similar. SCD needs to be differentiated from other
lipid keratopathies and particular from lethithin: choles-
terol acyltransferase disease (LCAT disease, Norum dis-
ease) and fish eye disease caused by different mutations in
the LCAT gene.
Management including treatment
Because the stromal corneal dystrophies extend exten-
sively or completely through the entire corneal stroma, a
penetrating keratoplasty or lamellar keratoplasty may be
eventually required when vision becomes significantly
impaired. As a temporary measure an ablation of the
superficial cornea may be practical especially if donor tis-
sue is not available.
C. Posterior corneal dystrophies
The group of the posterior corneal dystrophies includes
Fuchs corneal dystrophy (FECD), posterior polymor-
phous corneal dystrophy (PPCD), congenital hereditary
endothelial corneal dystrophy (CHED) and X-linked
endothelial corneal dystrophy (XECD). These diseases are
characterized by abnormalities of the corneal endothe-
lium and Descemet membrane. In most of them, a defec-
tive active fluid transport by the corneal endothelium
causes excessive edema of the corneal stroma and this
impairs the clarity of the cornea and reduces visual acuity.
Epidemiology
The prevalence of FECD differs markedly in different parts
of the world. It is common and the most prevalent corneal
dystrophy in the USA, where it affects. approximately 4%
of the population over the age of 40 years [108]. In the
USA, FECD was a leading indication for penetrating kerat-
oplasty and this surgical procedure accounted for 10–25%
of all corneal transplants in different series. This is a sig-
nificant number considering that the annual number of
corneal transplants in the USA is > 32,000. It is also com-
mon in other developed countries. FECD is much more
common and more severe in women than in men (3–
4:1). FECD is uncommon in Saudi Arabia and in the Chi-
nese of Singapore[109], and FECD is extremely rare in
Japan [110]. Corneal guttae are detected in a high percent-
age of individuals over the age of 40 years in certain coun-
tries, such as the USA.
PPCD and CHED are both rare, but CHED2 is more com-
mon than CHED1. Most cases of CHED2 have been iden-
tified in children of consanguineous parents from Saudi
Arabia [111], India [112-115], Pakistan [115], Myanmar
(Burma)[115] and Ireland [116,117]. It has also been rec-
ognized in Bosnia [111], the United Kingdom [113] and
in an American of Chinese ancestry [118]. To date, the
Harboyan syndrome has been reported in 11 different
families from different ethnic groups (Asian Indian, South
American Indian, Sephardi Jewish, Brazilian Portuguese,
Dutch, Gypsy, Moroccan and Dominican)[119]. XECD
has been identified in a single large Austrian pedigree.
Etiology
While several distinct posterior corneal dystrophies exist a
relationship between some of them has been suggested on
the basis of molecular genetic studies. Phenotypic hetero-
geneity and allelic heterogeneity exists. For example, a p.
Gly455Lys missense mutation in the COL8A2 gene, which
encodes the α2 chain of collagen type VIII, have been
detected in both FECD and PPCD [120]. Likewise, a muta-
tion in the TCF8 gene, which causes PPCD type 3, has
been found in one of 74 Chinese patients with FECD
[121] and a mutation in the SLC4A11 gene have been
detected in 4 individuals with late-onset FECD [109].
Clinical description, histopathologic findings, etiology, management
Fuchs corneal dystrophy (FECD, Fuchs endothelial corneal dystrophy, 
endo-epithelial corneal dystrophy, late hereditary endothelial 
dystrophy, MIM #136800)
FECD is a common bilateral slowly progressive corneal
disorder of aging [108,122,123]. As a rule, it presents clin-
ically during the fifth or sixth decade of life and seldom at
an earlier age. The characteristic clinical findings of FECD
are excrescences on a thickened Descemet membrane
(cornea guttae), generalized corneal edema and decreased
visual acuity. Initially FECD is asymptomatic, but corneal
guttae form in the central cornea and they are frequently
surrounded by a fine dusting of pigment dots. The guttae
have a glittering golden brown appearance on slit lamp
biomicroscopy and when viewed by retroillumination
they appear as small dew drops. Corneal endothelial
abnormalities can be detected clinically several yearsOrphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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before the patient becomes symptomatic. Vision becomes
hazy and glare begins as the corneal stroma and epithe-
lium become edematous. A loss of corneal clarity is fol-
lowed by painful episodes of recurrent corneal erosions,
and a severe impairment of visual acuity and sometimes
even blindness in the elderly population (Figure 55).
At first, stromal edema produces a blue-gray haze anterior
to Descemet membrane. The entire corneal stroma even-
tually thickens and develops a ground-glass appearance,
while Descemet membrane wrinkles. Epithelial edema
results in a characteristic fine pigskin texture designated
"bedewing". Fluid accumulates between the epithelial
cells and in a subepithelial location (bullous keratopathy)
and it bursts through the epithelium causing painful cor-
neal erosions. Eventually, the subepithelial edema and
discomfort diminishes, but visual acuity continues to
deteriorate as connective tissue replaces it. The corneal
abnormalities start centrally, but spread towards the cor-
neoscleral limbus. FECD is commonly associated with
cataracts.
In advanced cases of FECD, abnormalities are found in the
all layers of the cornea, but consistent abnormalities
involve the corneal endothelium and Descemet mem-
brane, its basement membrane. The underlying abnor-
mality in FECD results in a decline in the number of
functional endothelial cells, premature corneal endothe-
lial cell degeneration and apoptosis. Melanosomes are
often found within the endothelial cells (Figures 56 to
58). The corneal endothelium is attenuated over the gut-
tate excrescences and abnormal endothelial cells have
widened intercellular spaces, swollen mitochondria, a
dilated rough endoplasmic reticulum, and melanosomes.
The Na-K ATPase pump site density in endothelial cells is
decreased in FECD. Adherent to the posterior surface of
Descemet membrane some cells possess morphological
features of fibroblasts. The endothelial alterations precede
the epithelial changes.
Multiple excrescences (guttae) of differing size and shape
are evident on the posterior surface of Descemet mem-
brane and protrude into the anterior chamber (Figures 59
to 63). Some guttae are mushroom or anvil shaped. Oth-
ers are multilaminar warts or are buried in the multilami-
nar extracellular matrix. In FECD, the guttae are typically
more confluent and more centrally located than the guttae
of aging, which characteristically involve predominantly
the peripheral cornea (Hassall-Henle warts). Fissures
within some guttae are penetrated by cellular debris. The
distribution of the guttae can be visualized in flat prepara-
tions of Descemet membrane using phase-contrast micro-
scopy or scanning electron microscopy. Descemet
membrane is also multilayered and often irregularly
thickened (two to four times normal) due to an excessive
accumulation of collagen especially where the guttae are
most abundant. A multilaminar collagenous layer which
stains with variable intensity with the periodic acid-Schiff
Fuchs corneal dystrophy Figure 55
Fuchs corneal dystrophy. A markedly opaque cornea 
caused by extensive edema due to a loss of endothelial cells 
that normal maintain the hydrophilic corneal stroma in a 
deturgescent state.
Fuchs corneal dystrophy Figure 56
Fuchs corneal dystrophy. Light microscopic appearance 
of the corneal endothelium, Descemet membrane, and the 
adjacent corneal stroma showing guttae, a paucity of 
endothelial cells including some containing melanosomes. 
Hematoxylin and eosin stain.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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stain is commonly present. Some subjects with FECD
have multilaminar connective tissue posterior to
Descemet membrane, but without corneal guttae.
When viewed by TEM, Descemet membrane has a normal
3-μm-thick anterior banded layer and a normal non-
banded portion, but posteriorly it contains fusiform bun-
dles and sheets of wide-spacing (100-nm) collagen with a
macroperiodicity of 55 or 100 nm within amorphous
material and manifests sub-bands with a periodicity of
about 30–40 nm (Figure 60). Horizontal fibrils run per-
pendicular to the vertical bands. The wide-spacing colla-
gen forms a hexagonal pattern, which is evident in
tangential sections. This pattern is identical to that
observed in horizontal sections of the normal anterior-
banded Descemet membrane. Tissue specimens in
advanced cases of FECD contain a layer consisting of
Fuchs corneal dystrophy Figure 57
Fuchs corneal dystrophy. Transmission electron micro-
graph showing attenuated corneal endothelial cell with mark-
edly electron dense cytoplasm and haphazardly arranged 
filaments within Descemet membrane.
Fuchs corneal dystrophy Figure 58
Fuchs corneal dystrophy. Transmission electron micro-
graph of a melanosome containing corneal endothelial cell 
closely adherent to a collagenous layer with fibrils orientated 
in different directions (Reproduced with permission from 
Klintworth [2]).
Fuchs corneal dystrophy Figure 59
Fuchs corneal dystrophy. View of guttae on inner surface 
of the cornea by scanning electron microscopy.
Fuchs corneal dystrophy Figure 60
Fuchs corneal dystrophy. Transmission electron micro-
scopic view of broad-banded collagen within the thickened 
Descemet membrane.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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loosely packed thin collagen fibrils (20–30 nm in diame-
ter) with a 64-nm banding scattered within basement
membrane-like material. Groups of 10- to 20-nm-diame-
ter collagen fibrils are found next to the wide-spacing col-
lagen and may fuse with the horizontal fibrils of the wide-
spacing collagen. The excessive amounts of Descemet
membrane are of a type analogous to that assembled in
utero. In FECD corneas, Descemet membrane and its adja-
cent posterior collagenous contain similar collagen types
to age-matched controls and immunohistochemical stud-
ies have disclosed fibrinogen/fibrin in the posterior colla-
genous layer in FECD, but not in normal Descemet
membrane. Due to abnormal extracellular matrix deposits
within Descemet membrane in FECD, an immunohisto-
chemical study on selected cases of FECD as well as in situ
hybridization using labeled sense and antisense TGFBI
oligonucleotide probes was performed [124]. This study
disclosed the presence of transforming growth factor beta
induced protein in the sub-epithelial corneal matrix and
in the posterior collagenous layer of FECD.
Corneal edema is usually most marked in the central and
paracentral cornea and this overlies the abnormal corneal
endothelium. Initially, edema of the corneal epithelium is
restricted to the basal epithelial layer, but the more super-
ficial layers are also involved in more advanced cases and
the epithelium becomes separated from its basal lamina,
which is fragmented, and Bowman layer (bullous keratop-
athy) (Figures 61 to 63). This is associated with a loss of
hemidesmosomes. Bowman layer usually remains intact,
but focal breaks become traversed by subepithelial con-
nective tissue.
The cause of FECD is unknown, but it seems to be a heter-
ogenous complex inherited disorder caused by the inter-
action of genetic products and environmental factors.
Although most patients with FECD lack a positive family
history, blood relatives sometimes manifest corneal gut-
tae. FECD may also affect siblings and two or more succes-
sive generations apparently as an autosomal dominant
disorder having incomplete penetrance, but a simple
autosomal dominant pattern is unlikely. For reasons that
remain to be determined, FECD is expressed much more
frequently in females. Rare young onset cases of FECD
have been associated with mutations in the COL8A2 gene
[120]. Other cases of FECD have been mapped to chro-
mosome 13 (13pTe1-3q12.13) [125] and 18 (18q21.2–
q21.32) [126]. Two families with an early-onset auto-
somal dominant variant of FECD and PPCD have recently
been found to have a p. Gln455Lys mutation in the
COL8A2  gene suggesting that these two disorders are
related to each other. A p. Leu450Trp mutant in COL8A2
has also been found in early-onset FECD [127]. Hetero-
zygous mutation in the SLC4A11 gene have been detected
in 4 of 89 cases of late-onset FECD [109], but the signifi-
cance of these findings remains to determined as one
would expect all parents of persons with CHED2 to have
FECD. A single novel mutation in the TCF8 gene, which
causes PPCD type 3, was only found in one of 74 Chinese
patients with FECD [121].
The clinical course of FECD usually spans 10–20 years and
is characterized by a progressive edema of the corneal
stroma, epithelium and subepithelial tissue (bullous
keratopathy) and an eventual subepithelial fibrosis. Cata-
racts are common in individuals with FECD and cataract
extraction accelerates the corneal decompensation. Micro-
bial keratitis and corneal neovascularization are extremely
rare complications of FECD.
Most patients with FECD ultimately require a penetrating
keratoplasty or one of the more recent procedures for
repairing the posterior surface of the cornea, such as a
deep lamellar endothelial keratoplasty (DLEK), Descemet
stripping endothelial keratoplasty (DSEK), or Descemet
stripping automated endothelial keratoplasty (DSAEK).
Posterior polymorphous corneal dystrophy (PPCD, posterior 
polymorphous dystrophy, MIM #122000, #609140, #609141)
Small aggregates of apparent vesicles bordered by a gray
haze and gray geographic areas appear clinically at the
level of Descemet membrane in PPCD [128,129]. These
abnormalities occasionally appear nodular and contain
round or elliptical vesicular zones creating a pattern that
resembles Swiss cheese. Broad bands with more or less
parallel edges and gray sheets appear as thickenings of
Descemet membrane. These abnormalities exhibit a
refractile quality on retroillumination. Adhesions some-
times unite the iris with the posterior surface of the
peripheral cornea giving rise to glaucoma. These adhe-
sions differ in appearance from the fine strands that attach
iris to a prominent Schwab ring in the Axenfeld and Rieger
anomalies. PPCD is usually bilateral but the abnormali-
ties may be asymmetrical and sometimes only one cornea
is apparently affected. Most patients remain asympto-
matic and corneal edema is usually absent, presumably
because the corneal endothelium is able to maintain a
normal state of corneal hydration in most affected indi-
viduals. However, sometimes edema of the corneal epi-
thelium and stroma are present even at birth and the
anterior cornea may become scarred and develop calcific
band keratopathy. A single example of keratoglobus with
PPCD has been reported [130].
Unlike FECD, corneal guttae are not present on Descemet
membrane. Sometimes edema of the corneal epithelium
and stroma occur, and the anterior cornea may become
scarred and develop calcific band keratopathy. Corneal
tissue has only been examined in cases of PPCD with glau-
coma or those that are severe enough to require a pene-Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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trating keratoplasty. A major morphologic feature of
PPCD is the replacement of corneal endothelial with cells
having epithelial attributes. Instead of an endothelial
monolayer, the posterior cornea is lined by variable num-
bers of stratified squamous epithelial cells having tonofil-
aments, cytokeratin and desmosomes [131,132] (Figure
64 to 68). These epithelial cells have numerous microvilli,
but unlike normal corneal epithelium, microplicae are
not a feature. Descemet membrane is multilaminar and
irregularly thickened and occasionally with focal nodular
excrescences, but they differ from the corneal guttae that
characterize FECD. TEM of Descemet membrane has dis-
closed an anterior 3 μm thick, 110 nm banded layer and
an extremely thin posterior non-banded portion with
numerous delicate collagen fibrils (10–20 nm in diameter
with a normal cross-striational periodicity) as well as long
spacing collagen (with a banding of 55–110 nm) inter-
spersed with fine granular homogeneous basement mem-
brane-like material. That the banded anterior layer of
Descemet membrane is present and of normal thickness
suggests that the abnormality of the corneal endothelium
in PPCD does not become manifest until late in gestation.
The abnormal endothelial cells show strong immunos-
taining for a wide variety of cytokeratins, but express pre-
dominantly cytokeratin 7 and cytokeratin 19 [133].
Edema of the corneal epithelium and stroma may be
present in advanced cases.
PPCD is an autosomal dominant genetically heteroge-
nous entity with extremely variable expression. Three
genes have been implicated in PPCD (VSX1, COL8A2,
TCF8), but the evidence implicating VSX1 and COL8A2 is
questionable. p. Leu159Met and p. Gly160Asp mutations
in VSX1 have also been reported [134], but an analysis of
two large families in the Czech republic has shown that
the locus excludes the VSXI gene [135]. A missense p.
Gln455Lys mutation in the COL8A2 has also been identi-
fied in PPCD, but a tissue diagnosis in that family was not
documented [120]. Evidence for TCF8, which encodes
transcription factor 8, is much more convincing [136].
A yet to be identified gene for autosomal dominant PPCD
has also been mapped to the pericentromeric region of
human chromosome 20 (20q11) [137], where a gene for
CHED1 is also located. While PPCD and CHED1 may be
due to different genes one gene in this region could be
responsible for both corneal dystrophies. The latter seems
more likely because blood relatives of individuals with
PPCD may have CHED1 [138,139]. PPCD shares devel-
Fuchs corneal dystrophy Figure 61
Fuchs corneal dystrophy. A subepithelial bulla resulting 
from a separation of the corneal epithelium from Bowman 
layer. This bullous keratopathy is a manifestation of numer-
ous disorders of the cornea in which fluid accumulates 
beneath the corneal epithelium following a functionally defec-
tive endothelial layer.
Fuchs corneal dystrophy Figure 62
Fuchs corneal dystrophy. Light microscopic appearance 
of the cornea showing numerous excrescences on the poste-
rior surface of Descemet membrane (guttae) and the pres-
ence of cysts in the corneal epithelium beneath ectopically 
placed intraepithelial basement membrane. Periodic acid-
Schiff stain.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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opmental, morphological and clinical similarities with
CHED1, and one variant of PPCD is probably related to
CHED1.
PPCD is usually asymptomatic and hence most cases do
not require treatment. However, those that do usually
warrant a penetrating keratoplasty, or one of the current
therapeutic procedures advocated for FECD. PPCD can
recur in the graft following a penetrating keratoplasty. The
corneal endothelial changes often remain stationary for
years, but the disorder may progress slowing with time
leading to corneal endothelial decompensation and cor-
neal edema.
Congenital hereditary endothelial corneal dystrophy: congenital 
hereditary endothelial dystrophy type 1 (CHED1, autosomal 
dominant CHED, MIM #121700), congenital hereditary endothelial 
dystrophy type 2 (CHED2, Maumenee corneal dystrophy, autosomal 
recessive CHED, infantile hereditary endothelial dystrophy, MIM 
#217700)
CHED is characterized by a diffuse ground-glass appear-
ance of both corneas and markedly thickened (2–3 times
thicker than normal) corneas from birth or infancy (Fig-
ure 69). Two types of CHED are recognized: CHED1
(autosomal dominant) and CHED2 (autosomal reces-
sive) [140,141]. CHED1 becomes manifest during the
first two years of life with photophobia and tearing, but in
contrast to CHED2 nystagmus is absent. In CHED2,
affected individuals are born with corneas having a diffuse
ground glass appearance and this is accompanied by nys-
tagmus. CHED2 is sometimes associated with receptive
deafness (Harboyan syndrome) [142].
The cornea in CHED is swollen due to extensive stromal
edema (Figure 70) with some enlargement of collagen
fibrils. These changes, together with the decreased fibril
density, scatter light and result in a ground-glass appear-
ance of the cornea. The endothelial cells are scant or
degenerated when present. The corneal endothelium pre-
sumably functions normally in utero as evidenced by the
thin embryonic Descemet membrane, which consists of a
normal anterior 110 nm banded portion and a narrow
zone of posterior non-banded material (Figure 71). In
addition, there is a fibrous connective tissue layer poste-
rior to Descemet membrane, which is composed of an
admixture of fibrils measuring 20–40 nm in diameter and
small amounts of basement membrane-like material. In
some foci, the latter becomes densely packed and resem-
bles an additional layer of Descemet membrane. The kera-
tocytes and Bowman layer are usually unremarkable. The
histopathology of CHED1 and CHED2 are similar, but
subtle differences in the thickness of collagen in Descemet
membrane have been described. In CHED1, a posterior
collagenous layer of fibrillary collagen contributes to the
thickness of Descemet membrane. CHED2 cases show an
increased tendency for the abnormal endothelium to syn-
thesize a homogenous, posterior, non-banded Descemet.
As with PPCD, the corneal endothelial cells in CHED
express cytokeratin in contrast to normal corneal
endothelium [143], but unlike PPCD the endothelial
layer less often becomes multilayered [144]. Subepithelial
amyloidosis has been observed in cases of CHED2
[145,146] and it remains to be determined if this is a man-
ifestation of CHED2 or an associated GDCD in persons
with two different dystrophies.
The gene responsible for CHED1 has been mapped to the
pericentromeric region of chromosome 20 (20p11.2-
q11.2) in an area overlapping a gene for one type of PPCD
[147] and this distinct from the locus for CHED2 [116].
Most cases of CHED2 are caused by homozygous muta-
tions in the SLC4A11 gene [111-115,118,119,142] which
encodes bicarbonate transporter-related protein 1 that
reportedly regulates the intracellular boron concentration.
A high degree of mutational heterogeneity has been
detected in CHED2 [114] and genetic heterogeneity may
exist as no mutations in SLC4A11  or in its promoter
region have been detected in some families
[111,112,148].
Fuchs corneal dystrophy Figure 63
Fuchs corneal dystrophy. Higher magnification of the epi-
thelium in Figure 62 illustrating the intraepithelial cysts and 
ectopic epithelial basement membrane. This non-specific tis-
sue reaction occurs in many disorders affecting the corneal 
epithelium and is commonly referred to as epithelial base-
ment membrane dystrophy. Periodic acid-Schiff stain.Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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In CHED where bilateral corneal opacification is severe, a
penetrating keratoplasty is the only hope for improved
vision. CHED1 progresses slowly over 5–10 years, but
CHED2 remains stationary throughout life.
X-linked endothelial corneal dystrophy (XECD)
X-linked endothelial corneal dystrophy manifests as a
congenital ground glass corneal clouding or a diffuse cor-
neal haze [149]. In males this is often associated with
blurred vision. Advanced cases have a subepithelial band
keratopathy associated with endothelial changes that
resemble moon craters. Males are affected more severely
than females and the corneal opacification may be severe
and associated with nystagmus. Females are asympto-
matic, but have moon crater-like endothelial abnormali-
Posterior polymorphous corneal dystrophy Figure 66
Posterior polymorphous corneal dystrophy. Scanning 
electron microscopic view of the corneal endothelium show-
ing the surface profiles of endothelial (ENDO) and epithelial 
cells (EPI) (Reproduced with permission from Rodriques et 
al. [130]).
Posterior polymorphous corneal dystrophy Figure 64
Posterior polymorphous corneal dystrophy. Appear-
ance of the abnormal corneal endothelial cells that have 
become transformed into stratified squamous epithelium. 
Periodic acid Schiff stain. (Courtesy Dr. Ralph C. Eagle, Jr).
Posterior polymorphous corneal dystrophy Figure 65
Posterior polymorphous corneal dystrophy. Immuno-
histochemical demonstration of cytokeratin (stained brown) 
within the transformed corneal endothelium which has 
acquired the attributes of stratified squamous epithelium. 
Immunoperoxidase stain with antibody to cytokeratin.
Posterior polymorphous corneal dystrophy Figure 67
Posterior polymorphous corneal dystrophy. Transmis-
sion electron micrograph showing epithelial-like cells lining 
the inner surface of the cornea. (Reproduced with permis-
sion from Boruchoff and Kuwabara [131]).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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ties. In keeping with an X-linked mode of inheritance,
affected males transmit the disorder to their daughters,
but not to their sons.
Light microscopy and TEM have disclosed focal disconti-
nuities and degenerative changes in the corneal endothe-
lial cells in XECD accounting for the moon crater-like
changes seen clinically [150]. Moreover, Descemet mem-
brane is irregularly thickened with small pits and excava-
tions as well as abnormal anterior and posterior banded
zones. The posterior non-banded zone of Descemet mem-
brane is absent. The corneal epithelium and Bowman
zone may be irregularly thinned. In contrast to PPCD, epi-
thelial cells with desmosomes and bundles of tonofila-
ments have not been found to line Descemet membrane.
XECD has been mapped to the long arm of the X-chromo-
some (Xq25) [150]. The critical interval contains 72 genes
of which 7 code for putative transcription factors.
A penetrating keratoplasty is sometimes indicated in
XECD and the graft may remain clear for as long as 30
years. Because so few cases have been treated, the opti-
mum mode of therapy is uncertain. The course in XECD is
slowly progressive with intermittent corneal clouding and
a subepithelial band keratopathy develops in adulthood
starting in the peripheral cornea.
Differential diagnosis
The most important issues in the differential diagnosis of
stromal corneal dystrophies regard the following:
Fuchs corneal dystrophy
Corneal guttae are not specific for FECD and may arise as
part of corneal aging or as a response to interstitial kerati-
tis. They are also a feature of MCD. Because cataracts are
commonly associated with FECD, the differential diagno-
sis also includes aphakic bullous keratopathy and pseudo-
phakic bullous keratopathy. In FECD, the guttae are
typically more confluent and more centrally located than
the guttae of aging, which characteristically involve pre-
dominantly the peripheral cornea (Hassall-Henle warts).
The dome-shape, fissured appearance and lack of a multil-
aminar pattern of Hassall-Henle bodies usually distin-
guish them from the guttae of FECD. Fissures similar to
those in Hassall-Henle bodies are occasionally found in
the guttae of FECD, but they are less plentiful and not as
prominent.
Posterior polymorphous corneal dystrophy
A diffuse corneal edema in PPCD may simulate CHED1,
but the corneas are thicker in the latter condition. In con-
trast to PPCD corneas epithelial cells do not replace
endothelial cells on the posterior surface of Descemet
membrane in CHED1. PPCD needs to be differentiated
from an acquired posterior corneal opacification that fol-
lows recurrent uveitis and keratitis (posterior polymor-
phous keratopathy) [151]. PPCD needs to be
distinguished from other disorders in which the corneal
endothelium is replaced in part by a stratified squamous
epithelium, such as the iridocorneal endothelial (ICE)
syndrome and an epithelial ingrowth that follows a pene-
trating wound at the corneoscleral limbus.
Posterior polymorphous corneal dystrophy Figure 68
Posterior polymorphous corneal dystrophy. Scanning 
electron micrograph showing numerous microvilli on the 
surface of a corneal endothelial cell (Reproduced with per-
mission from Klintworth [2]).
Congenital hereditary endothelial dystrophy Figure 69
Congenital hereditary endothelial dystrophy. A mark-
edly opaque cornea due to stromal edema secondary to 
defective endothelial cells (Courtesy of Dr. Ahmed A. Hida-
jat).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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Congenital hereditary corneal dystrophy
CHED can be confused with other congenital causes of
corneal opacification, such as CSCD and Peters anomaly.
As mentioned above CHED also needs to be distinguished
from PPCD.
Diagnostic criteria
Clinical diagnoses of the different corneal dystrophies var-
ies with the different entities, but should be suspected
when corneal transparency is lost or corneal opacities
occur spontaneously particularly in both corneas espe-
cially in the presence of a positive family history or in the
offspring of consanguineous parents. Due to the ease of
examining the cornea, the clinician is typically able to
determine the level of anatomic involvement and the
morphological nature of the dystrophic abnormality that
determine the symptoms associated with any type of the
disease.
Diagnostic methods
The clinical diagnosis of the corneal dystrophies is based
on the age of onset and the clinical appearance of the cor-
nea on slit-lamp biomicroscopy. When corneal tissue is
excised, it should be examined by light microscopy and
TEM as this can establish the precise diagnosis of many
corneal dystrophies. For those dystrophies in which the
mutant genes have been identified, molecular genetic
analyses of the suspected gene can provide a precise diag-
nosis. Such diagnostic tests are available at several com-
mercial laboratories as well as at numerous research
laboratories. A molecular diagnosis can also be used to
confirm the diagnosis of a suspected corneal dystrophy in
cases associated with an atypical phenotype (unilateral
dystrophies, dystrophies that involve more than a single
layer of the cornea, dystrophies that are associated with
extraocular involvement) or given the absence of a family
history in each case. In vivo confocal microscopy has
shown significant discrete features in some corneal dystro-
phies and helps to differentiate some of them from each
other in the absence of a tissue diagnosis.
Genetic counseling
Since the clinical characteristics and mode of inheritance
of each of the well-defined corneal dystrophies is well
established and can be confirmed in most instances his-
topathologically or with appropriate analyses of the
responsible gene, affected individuals or their parents can
usually be provided with detailed information about their
particular corneal dystrophy. This can be particularly val-
uable in providing genetic counseling relevant to different
treatments and different prognoses.
Antenatal diagnosis
A prenatal diagnosis of corneal dystrophies that are
caused by a known genetic mutation can be made theoret-
ically by analyzing the DNA obtained at amniocentesis or
with a chorionic biopsy, but this has not been reported
and would not be justified ethically for these non-life
threatening diseases.
Congenital hereditary endothelial dystrophy type 2 Figure 70
Congenital hereditary endothelial dystrophy type 2. 
Macroscopic appearance of thick edematous cornea from a 
patient with CHED2 (left image) compared to control (right 
specimen) (Courtesy of Dr. Susan Kennedy).
Congenital hereditary endothelial dystrophy Figure 71
Congenital hereditary endothelial dystrophy. Trans-
mission electron micrograph of Descemet membrane and 
the corneal endothelium of a patient from an inbred family 
with CHED2 illustrating haphazardly arranged broad-banded 
collagen fibers within Descemet membrane (Courtesy of Dr. 
Susan Kennedy).Orphanet Journal of Rare Diseases 2009, 4:7 http://www.ojrd.com/content/4/1/7
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Unresolved questions
Knowledge about most corneal dystrophies remains rudi-
mentary and many unresolved questions remain. The his-
topathology of some corneal dystrophies, such as CSCD,
ERED, FCD, PACD, SMCD and XECD is poorly under-
stood, because of the limited number of corneal speci-
mens that have been studied and many more need to be
studied in surgically excised or postmortem material. The
genes for CHED1, ERED, LECD, PACD, SMCD and XECD
still need to be mapped and identified.
Now that the molecular genetic defect in several corneal
dystrophies has been established adequate explanations
for the apparent limitation of the manifestations to the
cornea remain to be determined. For example why is clin-
ical disease restricted to the cornea CHED2, when it is
known that the SLC4A11 gene is strongly expressed in the
numerous parts of the body (including kidney, salivary
gland, thyroid gland, testis and trachea)? Also, why is
CSCD not a systemic disorder with involvement of more
than the cornea considering that it is due a mutation in
the DCN gene that encodes the proteoglycan decorin that
is present in many parts of the body?
The relationship between PPCD and CHED still remains
uncertain despite distinct light microscopical, ultrastruc-
tural and immunohistochemical differences between
these conditions. Despite the recognition of patchy epi-
thelial-like alterations of the corneal endothelium in the
genetically heterogeneous PPCD and the absence of these
changes in CHED, which has marked corneal edema it
remains controversial as to whether these disorders of
posterior cornea are distinct or involve a common mech-
anistic process. That one variant of PPCD may be related
to CHED1 is raised by the finding of both disorders in the
same family [139] and the fact that CHED1 and PPCD
have both been mapped to pericentric region of chromo-
some 20.
Some unresolved questions relate to specific disorders.
For example, it remains to be determined whether genetic
heterogeneity exists in MCD because all cases of MCD can
not be explained by mutations in the coding region of
CHST6, by major deletions or insertions in the upstream
region, or by splice site mutations which create or destroy
signals for exon-intron splicing. Also, an adequate molec-
ular explanation for the various immunophenotypes of
MCD still defies explanation. Also, why does a defective
sulfotransferase involved in the biosynthesis of a normal
component of the cornea lead to an intracytoplasmic
accumulation of GAGs within keratocytes and the corneal
endothelium in MCD? Why do the normal degradative
enzymes of GAGs not degrade the storage material in
MCD?
An understanding of the pathobiology of each corneal
dystrophy will eventually require the development of ani-
mal models of the disorders. Thus far this has only been
established in PPCD, where ZEb1 heterozygous and null
mice show features of PPCD [152].
Newer in vivo imaging modalities may be able to better
characterize the corneal dystrophies, and enhance the
clinical description of the phenotypes. Future studies on
families with few affected individuals that have not been
clearly phenotyped are needed to determine whether
there may in fact be overlap in the phenotypes, or whether
the phenotypes are consistent using similar modalities.
The categories in the IC3D classification of the corneal
dystrophies provides a framework for considering the new
and established corneal dystrophies in terms of basic
molecular knowledge known about them.
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